Medications taken years ago may still be detectable in the gut microbiome, according to a large-scale study by the Institute of Genomics at the University of Tartu. By comparing prescription histories with stool samples from more than 2,500 participants in the Estonia Biobank’s Estonian Microbiome Cohort, researchers found that many commonly prescribed drugs were associated with lasting changes in gut bacteria, including detectable microbial “fingerprints” years after treatment ended.
The gut microbiome is the community of bacteria and other microorganisms living in the digestive tract. It contributes to digestion, immune function and overall health. Antibiotics are well known to disrupt these microbial communities, but the new findings suggest that their long-term effects may also be associated with a wide range of other medications.
Many commonly used drugs are linked to microbiome changes
Most of the medications examined in the study were associated with differences in the participants’ gut bacteria. The drugs included antidepressants, beta-blockers, proton pump inhibitors and benzodiazepines.
Beta-blockers are commonly prescribed for high blood pressure and some heart conditions. Proton pump inhibitors reduce stomach acid and are often used to treat acid reflux. Benzodiazepines are frequently prescribed for anxiety, while antidepressants can help manage depression and other mental health conditions.
“Most microbiome studies only consider current drugs, but our results show that past drug use may be just as important as a surprisingly strong factor in explaining differences in individual microbiomes,” said lead author Dr. Oliver Asmets.
The findings suggest that a person’s current medication list may not capture the full history relevant to their gut health. Previous treatments could help explain why gut microbiome composition differs substantially between individuals.
Different drugs in the same class may have different effects
One of the most notable findings involved benzodiazepines, a class of drugs commonly used to treat anxiety disorders. The researchers found that benzodiazepine use was associated with microbiome changes comparable to those observed with broad-spectrum antibiotics, which can affect many types of bacteria and substantially alter the gut’s microbial community.
However, medications within the same class did not necessarily show identical associations. Diazepam and alprazolam are both benzodiazepines used for similar conditions, but the study found that they appeared to differ in the extent to which they affected gut bacteria.
This suggests that microbiome effects may depend not only on a medication’s broader drug class but also on the specific drug being used.
Microbiome changes were observed after starting or stopping treatment
To examine whether medications might be contributing to the observed microbial differences, the researchers collected additional stool samples from a smaller group of participants. They looked for predictable changes in the microbiome when people began or stopped taking certain drugs.
The results provided additional evidence that the medications themselves contributed to at least some of the changes, rather than the associations simply reflecting pre-existing differences between patients. The follow-up group was relatively small, but researchers identified sustained effects linked to several medication categories, including proton pump inhibitors, selective serotonin reuptake inhibitors (SSRIs), and some antibiotics, including penicillin and macrolide combinations.
SSRIs are a widely prescribed type of antidepressant. Macrolide antibiotics are used to treat a range of bacterial infections.
Why past medication use matters in microbiome research
The findings have implications for studies examining connections between gut bacteria and disease. Microbiome differences may reflect not only a person’s current health and medication use but also treatments received years earlier.
If researchers do not account for previous medications, they could mistakenly attribute differences in particular microorganisms to a disease or another health-related factor when past drug exposure may have played a role.
At the same time, the study does not establish that the persistent microbial changes are harmful or that they cause specific health problems. It highlights how much remains unknown about the long-term relationship between medications and the gut microbiome.
“This is a comprehensive, systematic evaluation of long-term drug effects on the microbiome using real medical health records,” said corresponding author Professor Erin Oog. “We hope this will encourage researchers and clinicians to take drug history into account when interpreting microbiome data.”
Source: www.sciencedaily.com












